Abstract
An HPLC method for the quality control of famotidine (FMT) containing formulations has been developed and validated. The combination of a short monolithic column (Chromolith® RP-18e 50 × 4.6 mm i.d.) and an elevated flow rate (3.0 mL min−1) enabled the proposal of a high-throughput analytical scheme capable of reliable operation in a demanding industrial environment. Detection was carried out at 265 nm. Thorough validation of the method included linearity (5–150%), limits of detection (0.13%) and quantification (0.41%), selectivity, precision (within- and day-to-day), accuracy and ruggedness. The new method was applied successfully to the analysis of samples (assay, dissolution, dosage & blending uniformity) during the production of four validation batches of FMT-containing tablets.
Similar content being viewed by others
References
T. J. Humphries, Scand. J. Gastroenterol. 22, 55 (1987)
B. Simon, P. Muller, H.G. Dammann, Innere Medizin 11, 81 (1984)
T.J. Humphries and G.J. Merritt, Aliment. Pharmacol. Ther. 13, 18 (1999)
P.D. Tzanavaras, D.G. Themelis, Anal. Chim. Acta 588, 1 (2007)
D. Guillarme, D.T.T. Nguyen, S. Rudaz, J-L. Veuthey, Eur. J. Pharm. Biopharm. 68, 430 (2008)
M.E. Swartz, J. Liq. Chromatogr. Relat. Technol. 28, 1253 (2005)
M.W. Dong, LC-GC North America 25, 656 (2007)
K. Cabrera, D. Lubda, H-M. Eggenweiler, H. Minakuchi, K. Nakanishi, J. High Resolut. Chromatogr. 23, 93 (2000)
C.K. Zacharis, J. Chromatogr. Sci. 47, 443 (2009)
R. Isono, H. Kurokawa, N. Suzaki, M. Tomida, S. Kadil, T. Yamaguchi, Y. Fujita, Bunseki Kagaku 58, 715 (2009)
M.I. Walash, A. El-Brashy, N. El-Enany, M.E. Kamel, J. Fruoresc. 19, 333 (2009)
I.A. Darwish, S.A. Hussein, A.M. Mahmoud, A.I. Hassan, Spectrochim. Acta A 69, 33 (2008)
M.I. Walash, M.K. Sharaf-El-Din, M. El-Sayed Metwally, M.R. Shabana, J. Chin. Chem. Soc. (Taipei) 52, 71 (2005)
Z. Korićanac T. Jovanović, J. Petković, D. Minić, J. Serb. Chem. Soc. 69, 485 (2004)
M.S. Elazazy, A. Shalaby, M.N. Elbolkiny, H.M. Khalil, Chin. Pharm. J. 55, 481 (2003)
M.M. Ayad, A. Shalaby, H.E. Abdellatef, M.M. Hosny, Anal. Bioanal. Chem. 376, 710 (2003)
N. Rahman, M. Kashif, Anal. Sci. 19, 907 (2003)
N. Helali, N.T. Tran, L. Monser, M. Taverna, Talanta 74, 694 (2008)
T. Perez-Ruiz, C. Martinez-Lozano, V. Tomas, E. Bravo, R. Galera, J. Pharm. Biomed. Anal. 30, 1055 (2002)
N. Helali, L. Monser, J. Sep. Sci. 31, 276 (2008)
N. Helali, F. Darghouth, L. Monser, Chromatographia 60, 455 (2004)
C. Ho, H-M. Huang, S-Y. Hsu, C-Y. Shaw, B-L. Chang, Drug Dev. Ind. Pharm. 25, 379 (1999)
A. Zarghi, A. Shafaati, S.M. Foroutan, A. Khoddam, J. Pharm. Biomed. Anal. 39, 677 (2005)
United States Pharmacopoeia, USP30-NF25 2112 (2007)
S.L. Rivera, S. Ghodbane, Int. J. Pharm. 108, 31 (1994)
S. Wanwimolruk, A.R. Zoest, S.Z. Wanwimolruk, C.T. Hung, J. Chromatogr. B 572, 227 (1991)
P.D. Tzanavaras, D.G. Themelis, Anal. Chim. Acta 581, 89 (2007)
Food and Drug Administration: Guidance for Industry. Dissolution Testing of Immediate Release Solid Oral Dosage Forms (US Department of Health and Human Services/Food and Drug Administration/Center for Drug Evaluation and Research, Rockville MD, 1997)
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Tzanavaras, P.D. Development and validation of an ultra-fast liquid chromatographic method for the quality control of famotidine formulations using a short monolithic stationary phase. cent.eur.j.chem. 9, 446–452 (2011). https://doi.org/10.2478/s11532-011-0022-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.2478/s11532-011-0022-x